Västra Frölunda, Sweden

Marcel Linschoten


Average Co-Inventor Count = 2.8

ph-index = 6

Forward Citations = 59(Granted Patents)


Location History:

  • Mölndal, SE (2001 - 2003)
  • Huddinge, SE (2004)
  • Västra Frölunda, SE (2002 - 2008)

Company Filing History:


Years Active: 2001-2008

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Marcel Linschoten: Innovator in Pharmaceutical Chemistry

Introduction

Marcel Linschoten is a notable inventor based in Västra Frölunda, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 9 patents. His work primarily focuses on compounds that have therapeutic applications, particularly in the treatment of diseases associated with carboxypeptidase U.

Latest Patents

One of Linschoten's latest patents involves phosphinyloxy, oxime, and carboxylic acid derivatives that serve as carboxypeptidase U inhibitors. The invention relates to compounds of Formula I, along with their pharmaceutically acceptable salts or solvates. These compounds inhibit carboxypeptidase U, which can be crucial in preventing and treating various diseases linked to this enzyme. The patent also covers processes for preparing these new compounds, pharmaceutical compositions containing them, and their use in manufacturing medicaments for medical applications.

Career Highlights

Throughout his career, Marcel Linschoten has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB. His expertise in developing innovative compounds has positioned him as a valuable contributor to advancements in medical treatments.

Collaborations

Linschoten has collaborated with notable professionals in his field, including Olle Karlsson and Jan-Erik Nyström. These collaborations have likely enhanced the scope and impact of his research and inventions.

Conclusion

Marcel Linschoten's work in pharmaceutical chemistry exemplifies the importance of innovation in developing new therapeutic agents. His contributions through patents and collaborations continue to influence the medical field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…